Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.35 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2606337 | 0.89 | SMN1; SMN2 (0.43) | SMN1; SMN2RAB9ANPC1GAACCNE1 | |
| SCHEMBL999131 | 0.87 | FPR2 (0.40) | SMN1; SMN2FFAR2CCNE1CDK2CDK5 | |
| SCHEMBL2606472 | 0.85 | SMN1; SMN2 (0.40) | SMN1; SMN2RAB9ANPC1GAACCNE1 | |
| SCHEMBL2606372 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2RAB9ANPC1GAACCNE1 | |
| SCHEMBL2606370 | 0.84 | SMN1; SMN2 (0.41) | SMN1; SMN2RAB9ANPC1GAACCNE1 | |
| SCHEMBL2606356 | 0.83 | S1PR3 (0.40) | SMN1; SMN2RAB9ANPC1GAACCNE1 | |
| SCHEMBL1000481 | 0.81 | CCNE2 (0.39) | CCNE1CDK2CDK5 | |
| SCHEMBL13639766 | 0.81 | CCNE1 (0.43) | SMN1; SMN2RAB9ANPC1CCNE1CDK2 | |
| SCHEMBL2606368 | 0.80 | ALDH1A1 (0.39) | SMN1; SMN2RAB9AFFAR2NPC1GAA | |
| SCHEMBL1000515 | 0.79 | CCNE2 (0.39) | CCNE1CDK2CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2444397-A1 | Heteroaryl-ureas and their use as glucokinase activators | Novo Nordisk A/S (DK) | 2012-04-25 | — | — | EP | disclosed |